Since FAP is overexpressed in the tumor microenvironment and is generally absent from other tissues in healthy adults, some research groups have focused on utilizing FAP protease activity to selectively activate prodrugs at the tumor sites to enhance drug efficacy and reduce toxicity [2,11]. This evidence concerns the gene FAP and neoplasm.